Press Releases
April 2018
04.10.2018
04.10.2018
04.04.2018
04.03.2018
March 2018
03.29.2018
03.23.2018
03.19.2018
03.19.2018
03.12.2018
03.11.2018
03.09.2018
03.08.2018
Resource Library
Press Kits
These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.
View Press Kits DetailsContact Pfizer Media Relations
Media Contacts
United States, Canada, and Latin America
+1 212.733.1226
Europe, Middle East, and Africa
+44-(0)845.300.8033
Asia Pacific
+65.918.732.47
Email
[email protected]
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.
For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.
For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".
For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.
Social Media Feeds
Featured Stories
How AI Is Helping Match Patients to Clinical Trials Faster
Before researchers can determine whether a potential new treatment is effective, they have to find enough eligible volunteers willing and able to participate in a trial. This process represents one of the biggest challenges in drug development.
Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men. In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
